Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

Merck KGaA

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Merck KGaA's 2013 sales performance.

Merck KGaA

Merck/Pfizer’s cancer immunotherapy latecomer hits a snag

Merck/Pfizer’s cancer immunotherapy latecomer hits a snag Bavencio fails a key lung cancer trial. Merck KGaA and Pfizer’s catch-up attempt in the checkpoint inhibitor market has hit a setback after their Bavencio drug failed a key ... Merck and Pfizer have tried to put a brave face on the study, saying it had

After Axovant shock, Roivant pens diabetes deal with Poxel

After Axovant shock, Roivant pens diabetes deal with Poxel Acquires Merck Serono’s diabetes candidate imeglimin as part of the deal. ... by Merck Serono for type 2 diabetes, for $35m upfront and a $15m equity investment.

Merck forges closer ties with Cancer Research UK

Merck forges closer ties with Cancer Research UK Researchers at Merck KGaA will join forces with scientists at Cancer Research UK for an early-stage drug discovery alliance that expands on earlier projects between the two groups. ... The new arrangement comes at a time when Merck is pressing the

Roche’s Ocrevus is first primary progressive MS drug in EU

Roche’s Ocrevus is first primary progressive MS drug in EU One reason for the rapid take-up is clinical data showing that Ocrevus is more effective in relapsing MS than Merck KGaA’s beta interferon drug Rebif, as well as competitive

Novartis’ Extavia evades NICE restrictions on MS drugs

Novartis’ Extavia evades NICE restrictions on MS drugs The appraisal rejected four other interferons - Biogen’s Avonex and long-acting variant Plegridy, Bayer’s Betaferon, and Merck Serono’s Rebif - as well as Teva’s non-interferon MS therapy

[ Previous 5 results ] 11 12 13 14 15 16 17 18 19 20 [ Next 5 results ]

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Innovative Trials

Innovative Trials specialises in delivering effective global patient recruitment strategies for your clinical trials by adopting a patient and site-centric...

Latest intelligence

Diversity in clinical trials: looking back at our 2021 blogs
In this blog, we look back at the Innovative Trials' Equality & Diversity (E&D) committee blogs across 2021...
What does the future hold for Light-chain Amyloidosis?
Recent advances in the understanding and treatment are reforming pharma’s approach to the management of this rare disease. With a new standard of care rapidly developing, what does the landscape...
Webinar:
Securing a future for telehealth with immersive market research insights...